Skip to Content

Western Sierra Resource Corp WSRC

Morningstar Rating
$0.01 0.00 (7.55%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

WSRC is trading at a 261% premium.
Price
$0.01
Fair Value
$6.62
Uncertainty
Extreme
1-Star Price
$7.93
5-Star Price
$1.17
Economic Moat
Wkbt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WSRC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.000.01
52-Week Range
$0.000.04
Bid/Ask
$0.01 / $0.01
Market Cap
$3.30 Mil
Volume/Avg
550,448 / 64,852

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Western Sierra Resource Corp is a multifaceted resource company and revenue producer focused on applying and expanding its $40,500,000 water rights assets. The beneficial uses of its water rights include growing industrial hemp, manufacturing, and undertaking the related eco-friendly, high-yield, project.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
6

Valuation

Metric
WSRC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
WSRC
Quick Ratio
0.18
Current Ratio
0.43
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
WSRC
Return on Assets (Normalized)
−3.65%
Return on Equity (Normalized)
−4.05%
Return on Invested Capital (Normalized)
−3.96%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
XnmhldfkyStmk$82.1 Bil
Merck KGaA ADR
MKKGY
MlzwknzjlYbbpmp$75.2 Bil
Haleon PLC ADR
HLN
CcqclqdWrz$41.4 Bil
Viatris Inc
VTRS
HnrnydrpLlz$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
GlxsqhwxPnql$13.7 Bil
Catalent Inc
CTLT
JdbgshhyMkbvsy$10.6 Bil
Perrigo Co PLC
PRGO
MprhpkngFgr$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
JchhxyzgZmkpq$3.5 Bil
Curaleaf Holdings Inc
CURLF
PyjxrvlnSyvhv$3.0 Bil
Green Thumb Industries Inc
GTBIF
RkvtyldwjtDptr$2.7 Bil

Sponsor Center